SenGupta DJ, Unadkat JD (2004). Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep. Biochem Pharmacol. 67 (3): 453—458. doi:10.1016/j.bcp.2003.09.018. PMID15037197.
Patel J, Marangos PJ, Skolnick P, Paul SM, Martino AM (1982). Benzodiazepines are weak inhibitors of [3H]nitrobenzylthioinosine binding to adenosine uptake sites in brain. Neurosci Lett. 29 (1): 79—82. doi:10.1016/0304-3940(82)90368-8. PMID7070715.
York MJ, Davies LP (1982). The effect of diazepam on adenosine uptake and adenosine-stimulated adenylate cyclase in guinea-pig brain. Can J Physiol Pharmacol. 60 (3): 302—307. doi:10.1139/y82-041. PMID6280826.
Ujfalusi A, Cseppentö A, Nagy E, Szabó JZ, Kovács P, Szentmiklósi AJ (1999). Sensitization by chronic diazepam treatment of A2A adenosine receptor-mediated relaxation in rat pulmonary artery. Life Sci. 64 (2): PL19—25. doi:10.1016/S0024-3205(98)00547-5. PMID10069495.
Narimatsu E, Niiya T, Kawamata M, Namiki A (2008). Adenosine and adenosine uptake inhibitors potentiate the neuromuscular blocking action of rocuronium mediated by adenosine A(1) receptors in isolated rat diaphragms. Acta Anaesthesiol Scand. 52 (10): 1415—1422. doi:10.1111/j.1399-6576.2008.01714.x. PMID19025536.
Bender AS, Hertz L (1986). Similarities of adenosine uptake systems in astrocytes and neurons in primary cultures. Neurochem Res. 11 (11): 1507—1524. doi:10.1007/BF00965770. PMID2891057.
O'Regan MH, Phillis JW (1988). Potentiation of adenosine-evoked depression of rat cerebral cortical neurons by triazolam. Brain Res. 445 (2): 376—379. doi:10.1016/0006-8993(88)91203-6. PMID3370471.
Phillis JW, Delong RE (1984). A purinergic component in the central actions of meprobamate. Eur J Pharmacol. 101 (3–4): 295—297. doi:10.1016/0014-2999(84)90174-2. PMID6468504.
DeLong RE, Phillis JW, Barraco RA (1985). A possible role of endogenous adenosine in the sedative action of meprobamate. Eur J Pharmacol. 118 (3): 359—362. doi:10.1016/0014-2999(85)90149-9. PMID4085561.
Wang S; Cone J; Fong M; Yoshitake M; Kambayashi Ji; Liu Y (2001). Interplay between inhibition of adenosine uptake and phosphodiesterase type 3 on cardiac function by cilostazol, an agent to treat intermittent claudication. J Cardiovasc Pharmacol. 38 (5): 775—783. doi:10.1097/00005344-200111000-00014. PMID11602824.
Phillis JW, Wu PH (1982). The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp Biochem Physiol C. 72 (2): 179—187. doi:10.1016/0306-4492(82)90082-X. PMID6128137.
Phillis JW, Wu PH, Coffin VL (1983). Inhibition of adenosine uptake into rat brain synaptosomes by prostaglandins, benzodiazepines and other centrally active compounds. Gen Pharmacol. 14 (5): 475—479. doi:10.1016/0306-3623(83)90106-4. PMID6416920.
Noji T, Nan-ya K, Mizutani M, Katagiri C, Sano J, Takada C, Nishikawa S, Karasawa A, Kusaka H (2002). KF24345, an adenosine uptake inhibitor, ameliorates the severity and mortality of lethal acute pancreatitis via endogenous adenosine in mice. Eur J Pharmacol. 454 (1): 85—93. doi:10.1016/S0014-2999(02)02476-7. PMID12409009.
Lee CM, Cheung WT (1985). Inhibitory effect of adenosine on electrically evoked contractions in the rat vas deferens: pharmacological characterization. Neurosci Lett. 59 (1): 47—52. doi:10.1016/0304-3940(85)90213-7. PMID2995881.
Marangos PJ, Patel J, Clark-Rosenberg R, Martino AM (1982). [3H]nitrobenzylthioinosine binding as a probe for the study of adenosine uptake sites in brain. J. Neurochem. 39 (1): 184—191. doi:10.1111/j.1471-4159.1982.tb04717.x. PMID7086410.
Coffin VL, Taylor JA, Phillis JW, Altman HJ, Barraco RA (1984). Behavioral interaction of adenosine and methylxanthines on central purinergic systems. Neurosci Lett. 47 (2): 91—98. doi:10.1016/0304-3940(84)90412-9. PMID6205333.
Shi D, Daly JW (1999). Chronic effects of xanthines on levels of central receptors in mice. Cell Mol Neurobiol. 19 (6): 719—732. doi:10.1023/A:1006901005925. PMID10456233.
Phillis J.W. (1985). Chlorpromazine and trifluoperazine potentiate the action of adenosine on rat cerebral cortical neurons. Gen Pharmacol. 16 (1): 19—24. doi:10.1016/0306-3623(85)90264-2. PMID2984085.
Phillis J.W. (1984). Interactions of the anticonvulsants diphenylhydantoin and carbamazepine with adenosine on cerebral cortical neurons. Epilepsia. 25 (6): 765—772. doi:10.1111/j.1528-1157.1984.tb03489.x. PMID6510384.
SenGupta DJ, Unadkat JD (2004). Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep. Biochem Pharmacol. 67 (3): 453—458. doi:10.1016/j.bcp.2003.09.018. PMID15037197.
Narimatsu E, Niiya T, Kawamata M, Namiki A (2006). [The mechanisms of depression by benzodiazepines, barbiturates and propofol of excitatory synaptic transmissions mediated by adenosine neuromodulation]. Masui. 55 (6): 684—691. PMID16780077.
Patel J, Marangos PJ, Skolnick P, Paul SM, Martino AM (1982). Benzodiazepines are weak inhibitors of [3H]nitrobenzylthioinosine binding to adenosine uptake sites in brain. Neurosci Lett. 29 (1): 79—82. doi:10.1016/0304-3940(82)90368-8. PMID7070715.
York MJ, Davies LP (1982). The effect of diazepam on adenosine uptake and adenosine-stimulated adenylate cyclase in guinea-pig brain. Can J Physiol Pharmacol. 60 (3): 302—307. doi:10.1139/y82-041. PMID6280826.
Ujfalusi A, Cseppentö A, Nagy E, Szabó JZ, Kovács P, Szentmiklósi AJ (1999). Sensitization by chronic diazepam treatment of A2A adenosine receptor-mediated relaxation in rat pulmonary artery. Life Sci. 64 (2): PL19—25. doi:10.1016/S0024-3205(98)00547-5. PMID10069495.
Narimatsu E, Niiya T, Kawamata M, Namiki A (2008). Adenosine and adenosine uptake inhibitors potentiate the neuromuscular blocking action of rocuronium mediated by adenosine A(1) receptors in isolated rat diaphragms. Acta Anaesthesiol Scand. 52 (10): 1415—1422. doi:10.1111/j.1399-6576.2008.01714.x. PMID19025536.
Bender AS, Hertz L (1986). Similarities of adenosine uptake systems in astrocytes and neurons in primary cultures. Neurochem Res. 11 (11): 1507—1524. doi:10.1007/BF00965770. PMID2891057.
O'Regan MH, Phillis JW (1988). Potentiation of adenosine-evoked depression of rat cerebral cortical neurons by triazolam. Brain Res. 445 (2): 376—379. doi:10.1016/0006-8993(88)91203-6. PMID3370471.
Phillis JW, Delong RE (1984). A purinergic component in the central actions of meprobamate. Eur J Pharmacol. 101 (3–4): 295—297. doi:10.1016/0014-2999(84)90174-2. PMID6468504.
DeLong RE, Phillis JW, Barraco RA (1985). A possible role of endogenous adenosine in the sedative action of meprobamate. Eur J Pharmacol. 118 (3): 359—362. doi:10.1016/0014-2999(85)90149-9. PMID4085561.
Wang S; Cone J; Fong M; Yoshitake M; Kambayashi Ji; Liu Y (2001). Interplay between inhibition of adenosine uptake and phosphodiesterase type 3 on cardiac function by cilostazol, an agent to treat intermittent claudication. J Cardiovasc Pharmacol. 38 (5): 775—783. doi:10.1097/00005344-200111000-00014. PMID11602824.
Phillis JW, Wu PH (1982). The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp Biochem Physiol C. 72 (2): 179—187. doi:10.1016/0306-4492(82)90082-X. PMID6128137.
Phillis JW, Wu PH, Coffin VL (1983). Inhibition of adenosine uptake into rat brain synaptosomes by prostaglandins, benzodiazepines and other centrally active compounds. Gen Pharmacol. 14 (5): 475—479. doi:10.1016/0306-3623(83)90106-4. PMID6416920.
Ngai AC, Monsen MR, Ibayashi S, Ko KR, Winn HR (1989). Effect of inosine on pial arterioles: potentiation of adenosine-induced vasodilation. Am J Physiol. 256 (3 (Pt2)): H603—H606. PMID2923227.
Noji T, Nan-ya K, Mizutani M, Katagiri C, Sano J, Takada C, Nishikawa S, Karasawa A, Kusaka H (2002). KF24345, an adenosine uptake inhibitor, ameliorates the severity and mortality of lethal acute pancreatitis via endogenous adenosine in mice. Eur J Pharmacol. 454 (1): 85—93. doi:10.1016/S0014-2999(02)02476-7. PMID12409009.
Lee CM, Cheung WT (1985). Inhibitory effect of adenosine on electrically evoked contractions in the rat vas deferens: pharmacological characterization. Neurosci Lett. 59 (1): 47—52. doi:10.1016/0304-3940(85)90213-7. PMID2995881.
Marangos PJ, Patel J, Clark-Rosenberg R, Martino AM (1982). [3H]nitrobenzylthioinosine binding as a probe for the study of adenosine uptake sites in brain. J. Neurochem. 39 (1): 184—191. doi:10.1111/j.1471-4159.1982.tb04717.x. PMID7086410.
Coffin VL, Taylor JA, Phillis JW, Altman HJ, Barraco RA (1984). Behavioral interaction of adenosine and methylxanthines on central purinergic systems. Neurosci Lett. 47 (2): 91—98. doi:10.1016/0304-3940(84)90412-9. PMID6205333.
Shi D, Daly JW (1999). Chronic effects of xanthines on levels of central receptors in mice. Cell Mol Neurobiol. 19 (6): 719—732. doi:10.1023/A:1006901005925. PMID10456233.
Phillis J.W. (1985). Chlorpromazine and trifluoperazine potentiate the action of adenosine on rat cerebral cortical neurons. Gen Pharmacol. 16 (1): 19—24. doi:10.1016/0306-3623(85)90264-2. PMID2984085.
Phillis J.W. (1984). Interactions of the anticonvulsants diphenylhydantoin and carbamazepine with adenosine on cerebral cortical neurons. Epilepsia. 25 (6): 765—772. doi:10.1111/j.1528-1157.1984.tb03489.x. PMID6510384.
